WO2007009701A3 - Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome - Google Patents
Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome Download PDFInfo
- Publication number
- WO2007009701A3 WO2007009701A3 PCT/EP2006/006975 EP2006006975W WO2007009701A3 WO 2007009701 A3 WO2007009701 A3 WO 2007009701A3 EP 2006006975 W EP2006006975 W EP 2006006975W WO 2007009701 A3 WO2007009701 A3 WO 2007009701A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- metabolic syndrome
- combinations
- pyrazole compounds
- substituted pyrazole
- Prior art date
Links
- NOIXNOMHHWGUTG-UHFFFAOYSA-N 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline Chemical class C=1C=C(OCC=2N=C3C=CC=CC3=CC=2)C=CC=1C1=NN(CC(F)(F)F)C=C1C1=CC=NC=C1 NOIXNOMHHWGUTG-UHFFFAOYSA-N 0.000 title abstract 2
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05384014 | 2005-07-15 | ||
EP05384014A EP1743637A1 (en) | 2005-07-15 | 2005-07-15 | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
US70545105P | 2005-08-05 | 2005-08-05 | |
US60/705,451 | 2005-08-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007009701A2 WO2007009701A2 (en) | 2007-01-25 |
WO2007009701A3 true WO2007009701A3 (en) | 2007-04-12 |
Family
ID=37595549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/006975 WO2007009701A2 (en) | 2005-07-15 | 2006-07-15 | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2326723B1 (en) |
WO (1) | WO2007009701A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7923465B2 (en) | 2005-06-02 | 2011-04-12 | Glenmark Pharmaceuticals S.A. | Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
FR2919184A1 (en) * | 2007-07-26 | 2009-01-30 | Sanofi Aventis Sa | Use of 5-(4-chlorophennyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid as a medicament for treating e.g. chronic pain, neuropathic pain, inflammation, benign hypertrophy of the prostate and diabetic neuropathy |
DE102008015033A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted (pyrazolyl-carbonyl) imidazolidinones and their use |
DE102008015032A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted pyrazolamides and their use |
DE102008062863A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted (thiophenyl-carbonyl) imidazolidinones and their use |
DE102008062878A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted furancarboxamides and their use |
DE102009036604A1 (en) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituted bis-arylpyrazolamides with terminal primary amide functionality and their use |
DE102011055815A1 (en) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamide-substituted heteroaryl-pyrazoles and their use |
DE102012016908A1 (en) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris (hetero) aryl-pyrazoles and their use |
WO2014174457A1 (en) | 2013-04-23 | 2014-10-30 | Council Of Scientific & Industrial Research | Pyrazole carboxylic acid analogues as anti-mycobacterial drug candidates |
WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1384477A1 (en) * | 2001-04-06 | 2004-01-28 | Laboratorios Del Dr. Esteve, S.A. | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
WO2005077911A1 (en) * | 2004-02-17 | 2005-08-25 | Laboratorios Del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
WO2005077909A1 (en) * | 2004-02-17 | 2005-08-25 | Laboratorios Dr. Esteve S.A. | Substituted pyrazoline compounds for reducing triglycerides in blood |
-
2006
- 2006-07-15 ES ES200850006A patent/ES2326723B1/en not_active Expired - Fee Related
- 2006-07-15 WO PCT/EP2006/006975 patent/WO2007009701A2/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1384477A1 (en) * | 2001-04-06 | 2004-01-28 | Laboratorios Del Dr. Esteve, S.A. | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
WO2005077911A1 (en) * | 2004-02-17 | 2005-08-25 | Laboratorios Del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
WO2005077909A1 (en) * | 2004-02-17 | 2005-08-25 | Laboratorios Dr. Esteve S.A. | Substituted pyrazoline compounds for reducing triglycerides in blood |
Non-Patent Citations (3)
Title |
---|
"Der Begriff "Metabolisches Syndrom" ist unklar", DEUTSCHE APOTHEKER ZEITUNG, vol. 42, 20 October 2005 (2005-10-20), pages 8, XP002360775 * |
ECKEL R H ET AL: "The metabolic syndrome", LANCET THE, LANCET LIMITED. LONDON, GB, vol. 365, no. 9468, 16 April 2005 (2005-04-16), pages 1415 - 1428, XP004849990, ISSN: 0140-6736 * |
SIDDALL R: "RIO-DIABETES: RIMONABANT SHOWS PROMISE IN TYPE 2 DIABETES", BRITISH JOURNAL OF CARDIOLOGY, LONDON, GB, vol. 12, no. 4, July 2005 (2005-07-01), pages 257, XP009053958, ISSN: 0969-6113 * |
Also Published As
Publication number | Publication date |
---|---|
ES2326723A1 (en) | 2009-10-16 |
ES2326723B1 (en) | 2010-05-11 |
WO2007009701A2 (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007009701A3 (en) | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome | |
HK1199874A1 (en) | Spiro-oxindole compounds and their uses as therapeutic agents | |
EP1884513A4 (en) | Pyrazole compound and therapeutic agent for diabetes comprising the same | |
WO2007115821A3 (en) | Organic compounds | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
HK1166983A1 (en) | Solid forms comprising compounds for the treatment of diseases or disorders, compositions thereof, and use therewith | |
IL198289A (en) | Substituted dihydropyrazolones, processes for their preparation, medicaments comprising them and their use for the preparation of such medicaments | |
WO2007044084A3 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
IL177450A0 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
IL186615A0 (en) | Spiroheterocylic compounds and their uses as therapeutic agents | |
IL193467A0 (en) | Substituted indazole derivatives, their manufacture and use as pharmaceutical agents | |
IL198411A0 (en) | Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide | |
IL189394A0 (en) | Substituted pyrazolecarboxylic acid anilide derivatives and agricultural compositions containing the same | |
TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2008087367A3 (en) | Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same | |
EP2045253A4 (en) | alpha-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT | |
WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
WO2008087366A3 (en) | Substituted 3-phenyl-1-(phenylthienyl)propan-1-one and 3-phenyl-1-(phenylfuranyl)propan-1-one derivatives, and preparation and use of same | |
WO2010077339A3 (en) | β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF | |
WO2007009686A3 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
ZA200711041B (en) | Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same | |
IL186022A0 (en) | Dermatological compositions and salts for the treatment of dermatological diseases | |
WO2009074498A8 (en) | Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 200850006 Country of ref document: ES Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: P200850006 Country of ref document: ES |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06762617 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06762617 Country of ref document: EP Kind code of ref document: A2 |
|
WWP | Wipo information: published in national office |
Ref document number: 200850006 Country of ref document: ES Kind code of ref document: A |
|
WWG | Wipo information: grant in national office |
Ref document number: 200850006 Country of ref document: ES Kind code of ref document: A |